We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease

Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Neurol. 2013;70(6):772-773. doi:10.1001/jamaneurol.2013.1502.
Text Size: A A A
Published online


Immunotherapy for Alzheimer disease was advanced in reports1,2 showing that the use of Aβ42 peptide vaccination in a transgenic mouse model of Alzheimer disease significantly reduced the Aβ42 plaque count, significantly reduced levels of gliosis, and significantly improved behavior. Based on the positive experimental animal model data, a human Aβ42 peptide immunization clinical trial [ie, the AN1792(QS-21)-201 trial]3 for patients with Alzheimer disease was conducted; however, it was stopped owing to significant adverse effects in 6% of immunized patients. Subsequent studies showed that there were significant reductions in Aβ42-containing plaque in the brain but that the patients continued to become more demented.4 For patients with mild Alzheimer disease, the use of passive immunotherapy with the humanized monoclonal antibody bapineuzumab resulted in no significant clinical benefit, but the use of passive immunotherapy with the humanized monoclonal antibody solanezumab resulted in some memory and behavioral benefits (New York Times, July 24, 2012). Intravenous immunoglobulins, which probably contain anti-Aβ antibodies, have also been used to treat patients with Alzheimer disease, and their use has resulted in clinical stabilization.5

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

5 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Alzheimer Disease: "It's OK, Mama, If You Want to Go, It's OK"

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Supplemental Content